About us

NBE-Therapeutics is a privately owned Swiss, Basel-based Biotech company that was founded in 2012 with the vision to develop next-generation ADCs improving treatment options for cancer patients.

read more

Vision and Strategy

It is NBE Therapeutics vision to become a leader in antibody-based drug development by developing its own portfolio of drugs until demonstration of a clinical proof-of-concept in man.

read more

Research & Development

NBE-Therapeutics will leverage its in-house developed Transpo-mAb and SMAC-Technology for the development of potent next-generation ADC product candidates providing improved treatment options for cancer patients.

read more